LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has been notified by the National Cancer Institute of the U.S. National Institutes of Health that it has been awarded a $100,000 Small Business Innovation Research grant for research that is expected to result in improved predictive capabilities in its ADMET Predictor™ software product.
